Delivery Order SPE2DB22D3401-SPE2DB25FT0JM
Award Date
10/28/24
Potential Completion Date
10/29/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $1,105.65 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 11, 2024. The contract has an ultimate completion date of October 15, 2024 and is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,604.16, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
The federal contract award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,340.54 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 22, 2025, with an ultimate completion date of May 23, 2025. The contract is not set-aside and is a delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,523.80 firm fixed-price delivery order is for ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of November 21, 2024. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,097.77 firm-fixed-price delivery order contract was awarded on June 5, 2025 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of June 6, 2025. This order is not a set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $31,397.94 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 10, 2025 with a completion date of June 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the U.S. Defense Logistics Agency (DLA). The $21,084.81 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 9, 2024. The contract has an ultimate completion date of August 12, 2024 and does not utilize any set-aside designations. This award appears to be associated with a larger Indefinite Delivery Contract between...
This federal contract award is for the delivery of 4566087305 ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML medical products to the Defense Logistics Agency (DLA). The contract, valued at $2,948.40, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 11, 2024, with a completion date of October 15, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with various...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,586.44 firm fixed-price delivery order contract is for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of February 3, 2025. While the original solicitation was not provided, the award indicates that this is part of a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,878.70 Firm Fixed Price Delivery Order contract is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of February 24, 2025 and was awarded on February 21, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...